Biotech

All Articles

Praxis epilepsy drug reduces seizures in period 2 hearing

.Praxis Precision Medicines has scored one more midphase win in epilepsy this year, along with its o...

Three execs resign as Dyne posts blended information for DMD candidate

.After running away a scientific grip many years back, Dyne Therapy has actually exposed brand-new s...

Arrowhead fires off stage 3 information in uncommon metabolic condition before market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its give ahead of a prospective showdown with Ioni...

Pfizer, Valneva reveal lyme health condition go reliable for 2nd enhancer

.Pfizer as well as Valneva may have concerning 2 additional years to hang around just before they cr...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a conversation with Ayla Ellison, Strong Biotech Editor-in-Chief and also Michelle Benz...

New information demonstrate how Bayer's asundexian fell short to prevent movements

.Bayer suspended the period 3 trial for its element XIa inhibitor asundexian behind time in 2013 aft...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the F...

Galapagos' stock up as fund presents intent to mold its development

.Galapagos is happening under extra tension from real estate investors. Having built a 9.9% stake in...

Cell- focused Sana scoops very first CSO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...

Allist pays off Jacobio $21M, landing role in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has actually gotten itself a starring job in China's KRAS market, p...